Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 123
Filter
Add more filters

Country/Region as subject
Publication year range
1.
Mol Psychiatry ; 22(10): 1473-1482, 2017 10.
Article in English | MEDLINE | ID: mdl-28138157

ABSTRACT

Manic episodes are one of the major diagnostic symptoms in a spectrum of neuropsychiatric disorders that include schizophrenia, obsessive-compulsive disorder and bipolar disorder (BD). Despite a possible association between BD and the gene encoding phospholipase CƎĀ³1 (PLCG1), its etiological basis remains unclear. Here, we report that mice lacking phospholipase CƎĀ³1 (PLCƎĀ³1) in the forebrain (Plcg1f/f; CaMKII) exhibit hyperactivity, decreased anxiety-like behavior, reduced depressive-related behavior, hyperhedonia, hyperphagia, impaired learning and memory and exaggerated startle responses. Inhibitory transmission in hippocampal pyramidal neurons and striatal dopamine receptor D1-expressing neurons of Plcg1-deficient mice was significantly reduced. The decrease in inhibitory transmission is likely due to a reduced number of ƎĀ³-aminobutyric acid (GABA)-ergic boutons, which may result from impaired localization and/or stabilization of postsynaptic CaMKII (Ca2+/calmodulin-dependent protein kinase II) at inhibitory synapses. Moreover, mutant mice display impaired brain-derived neurotrophic factor-tropomyosin receptor kinase B-dependent synaptic plasticity in the hippocampus, which could account for deficits of spatial memory. Lithium and valproate, the drugs presently used to treat mania associated with BD, rescued the hyperactive phenotypes of Plcg1f/f; CaMKII mice. These findings provide evidence that PLCƎĀ³1 is critical for synaptic function and plasticity and that the loss of PLCƎĀ³1 from the forebrain results in manic-like behavior.


Subject(s)
Bipolar Disorder/enzymology , Bipolar Disorder/genetics , Phospholipase C gamma/metabolism , Prosencephalon/enzymology , Animals , Bipolar Disorder/parasitology , Brain-Derived Neurotrophic Factor/metabolism , Calcium-Calmodulin-Dependent Protein Kinase Type 2/metabolism , Hippocampus/enzymology , Hippocampus/metabolism , Mice , Neuronal Plasticity/physiology , Neurons/enzymology , Neurons/metabolism , Phospholipase C gamma/deficiency , Phospholipase C gamma/genetics , Prosencephalon/pathology , Pyramidal Cells/metabolism , Receptor, trkB/metabolism , Receptors, Dopamine D1 , Synapses/enzymology , Synapses/pathology , Synaptic Transmission/physiology , gamma-Aminobutyric Acid/metabolism
2.
Clin Lab ; 57(11-12): 959-67, 2011.
Article in English | MEDLINE | ID: mdl-22239028

ABSTRACT

BACKGROUND: Human enteroviruses (HEVs) are a major cause of herpangina, HFMD (hand, foot, and mouth disease), and other neurological diseases in Seoul, Korea. METHODS: A total of 56 specimens from hospitalized patients collected from February to December 2009 (37 females and 19 males) in Seoul were tested for HEV from stool, throat swab, and vesicle swab samples taken from patients with herpangina or HFMD using cell culture and RT-PCR in 2009. By the 1D gene, encoding the VP1 capsid protein, seven different HEV genotypes were detected with Coxsackievirus A2, A4, A5, A9, A16 (CA), Coxsackievirus B1 (CB), and Enterovirus 71 (EV71). The most prevalent genotype was CA16 (6, 10.7%), followed by CA2 (4, 7.1%), CA5 (4, 7.1%), EV71 (2, 3.6%), CA4 (1, 1.8%), CA9 (1, 1.8%), and CB1 (1, 1.8%). The 1D gene sequences of two EV71 strains were closely related with one another (98.5% nucleotide similarity) and belonged to the C4 genotype. CONCLUSIONS: It is important to continuously survey the genetic characteristics of EV71 and CA16 from patients, which will provide useful data that aids in our understanding of HFMD infections in Seoul, Korea and may contribute to future control.


Subject(s)
Coxsackievirus Infections/virology , Disease Outbreaks , Enterovirus Infections/virology , Enterovirus/isolation & purification , Hand, Foot and Mouth Disease/virology , Herpangina/virology , Capsid Proteins/genetics , Child, Preschool , Coxsackievirus Infections/epidemiology , Enterovirus/genetics , Enterovirus A, Human/genetics , Enterovirus A, Human/isolation & purification , Enterovirus B, Human/genetics , Enterovirus B, Human/isolation & purification , Enterovirus Infections/epidemiology , Feces/virology , Female , Hand, Foot and Mouth Disease/epidemiology , Herpangina/epidemiology , Humans , Infant , Infant, Newborn , Male , Pharynx/virology , Phylogeny , RNA, Viral/genetics , RNA, Viral/isolation & purification , Republic of Korea/epidemiology , Sequence Analysis, RNA
3.
J Hosp Infect ; 104(4): 476-483, 2020 Apr.
Article in English | MEDLINE | ID: mdl-31785319

ABSTRACT

BACKGROUND: Concerns are growing over the importance of the hospital water environment for the transmission of carbapenemase-producing Enterobacteriaceae (CPE). AIM: To report a large outbreak in the cardiology units involving intensive care units (ICUs) and wards at a tertiary-care hospital. METHODS: This was a contact tracing, case-control study to find the risk factors for acquisition of CPE and environmental sampling was performed during a CPE outbreak between July and December 2018. FINDINGS: A total of 87 patients with CPE infection or colonization were identified in the cardiology units of the Asan Medical Centre. Diverse organisms were identified containing blakpc, blaNDM-1, blaVIM or blaIMP, blaOXA-48, and co-producing organisms. A case-control study indicated that using the sinks in the ward patient room bathroom for teeth brushing was associated with CPE acquisition (83% vs 30%; P=0.03). The environment was cultured and Klebsiella pneumoniae carbapenemase (KPC)-producing Escherichia coli was isolated from a water dispenser and New Delhi metallo-beta-lactamase (NDM) 1-producing Citrobacter freundii and Enterobacter cloacae from sinks in patient rooms. Pulsed-field gel electrophoresis (PFGE) analysis of KPC-producing E.Ā coli from patients and the water dispenser in ICU and NDM-1-producing E.Ā cloacae from the patient and sink drain showed the same pulsotypes. CONCLUSIONS: The water dispenser and sink drain were suspected as possible reservoirs of CPE in this outbreak. Close contacts with contaminated water such as tooth brushing were identified as risk factors for CPE acquisition. Education for the adequate use of the water environment system as well as the control of the hospital water environment should be implemented to prevent the CPE outbreaks.


Subject(s)
Carbapenem-Resistant Enterobacteriaceae/isolation & purification , Enterobacteriaceae Infections/etiology , Enterobacteriaceae Infections/microbiology , Equipment Contamination , Water Microbiology , Aged , Carbapenem-Resistant Enterobacteriaceae/genetics , Cardiology , Case-Control Studies , Disease Outbreaks , Enterobacteriaceae , Female , Hospital Units , Hospitals , Humans , Male , Middle Aged , Republic of Korea/epidemiology , Risk Factors , Surveys and Questionnaires
4.
Epidemiol Psychiatr Sci ; 29: e176, 2020 Oct 20.
Article in English | MEDLINE | ID: mdl-33077022

ABSTRACT

AIMS: To investigate the association between parity and the risk of incident dementia in women. METHODS: We pooled baseline and follow-up data for community-dwelling women aged 60 or older from six population-based, prospective cohort studies from four European and two Asian countries. We investigated the association between parity and incident dementia using Cox proportional hazards regression models adjusted for age, educational level, hypertension, diabetes mellitus and cohort, with additional analysis by dementia subtype (Alzheimer dementia (AD) and non-Alzheimer dementia (NAD)). RESULTS: Of 9756 women dementia-free at baseline, 7010 completed one or more follow-up assessments. The mean follow-up duration was 5.4 Ā± 3.1 years and dementia developed in 550 participants. The number of parities was associated with the risk of incident dementia (hazard ratio (HR) = 1.07, 95% confidence interval (CI) = 1.02-1.13). Grand multiparity (five or more parities) increased the risk of dementia by 30% compared to 1-4 parities (HR = 1.30, 95% CI = 1.02-1.67). The risk of NAD increased by 12% for every parity (HR = 1.12, 95% CI = 1.02-1.23) and by 60% for grand multiparity (HR = 1.60, 95% CI = 1.00-2.55), but the risk of AD was not significantly associated with parity. CONCLUSIONS: Grand multiparity is a significant risk factor for dementia in women. This may have particularly important implications for women in low and middle-income countries where the fertility rate and prevalence of grand multiparity are high.


Subject(s)
Alzheimer Disease/epidemiology , Dementia/epidemiology , Parity/physiology , Aged , Aged, 80 and over , China/epidemiology , Cohort Studies , Europe/epidemiology , Female , Geriatric Psychiatry , Humans , Incidence , Independent Living , Middle Aged , Pregnancy , Proportional Hazards Models , Republic of Korea/epidemiology , Risk Factors , Socioeconomic Factors
5.
Science ; 244(4904): 546-50, 1989 May 05.
Article in English | MEDLINE | ID: mdl-2541501

ABSTRACT

Inositol phospholipid-specific phospholipase C is the enzyme that generates phosphoinositide-derived messenger molecules. Mammalian cells contain at least five immunologically distinct phospholipase C enzymes that appear to be separate gene products. Complete amino acid sequences of four of these isozymes have been established. The overall sequence similarity is surprisingly low for enzymes catalyzing the same chemical reaction: three of them show limited amino acid sequence similarity to each other in two narrow regions, and the fourth enzyme is completely different. The diversity in primary structure together with different regional and cellular expression of the isozymes suggests that each isozyme has a defined function in processing the physiological response of different cell types to a variety of external stimuli and that each is regulated differently.


Subject(s)
Isoenzymes/metabolism , Phosphatidylinositols/metabolism , Phosphoric Diester Hydrolases/metabolism , Amino Acid Sequence , Animals , Cell Membrane/enzymology , Cytosol/enzymology , Phosphoinositide Phospholipase C , Phosphorylation , Second Messenger Systems , Terminology as Topic
6.
Clin Pharmacol Ther ; 81(4): 539-46, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17192767

ABSTRACT

P-glycoprotein (PGP) is a polymorphic transporter encoded by the ABCB1 gene that contributes to the access of xenobiotics into the brain. There is no report on associations between genetic polymorphisms in ABCB1 and the clinical effects of fentanyl, although fentanyl may be a substrate of PGP. One hundred and twenty-six (126) unrelated Korean patients under spinal anesthesia with intravenous fentanyl (2.5 microg/kg) were recruited. Clinical effects (bispectral index, respiration rate, and need for oxygen supplementation) were monitored and these were compared between genotypes for three single nucleotide polymorphisms in ABCB1 (1236C>T, 2677G>T/A, and 3435C>T). The allele and genotype frequencies were similar to previous data from Asians; the three major haplotypes, TTT (30%), TGC (24%), and CGC (24%) were expected among nine known haplotypes. During the initial 10 min, there were differences in suppression of respiration rate by fentanyl among the three genotypes (P=0.0933 for 1236C>T; P=0.0941 for 2677G>A/T; P=0.0013 for 3435C>T, repeated-measures analysis of variance), but the differences in bispectral index among genotypes were not observed. Furthermore, patients carrying the linked 3435T and 2677T alleles showed a significant difference in the level of respiratory suppression (P=0.0056); those with genotypes susceptible to fentanyl (1236TT, 2677TT, and 3435TT) showed early (2-3 min) and profound suppression of respiration (65-73% of initial respiration rate) compared with other resistant genotypes (83-85% of initial respiration rate in 1236CC, 2677GG, and 3435CC). Although the need to supply oxygen was not significantly different between genotypes, there was a trend for increased demand by patients carrying both 1236T and 3435T alleles (P=0.0847). In conclusion, our results confirm ABCB1 genotype data for Koreans and suggest that analysis of ABCB1 polymorphisms may have clinical relevance to prevent respiratory suppression by intravenous fentanyl or to anticipate its clinical effects.


Subject(s)
Anesthesia, Spinal , Anesthetics, Intravenous , Fentanyl , Organic Anion Transporters/genetics , ATP Binding Cassette Transporter, Subfamily B , ATP Binding Cassette Transporter, Subfamily B, Member 1 , Adult , Aged , Electrocardiography/drug effects , Female , Genotype , Haplotypes , Humans , Korea/epidemiology , Male , Middle Aged , Oxygen Consumption/drug effects , Polymorphism, Genetic/genetics , Polymorphism, Single Nucleotide/genetics , Respiratory Mechanics/drug effects
7.
Mol Biol Cell ; 11(12): 4359-68, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11102529

ABSTRACT

G protein-coupled and tyrosine kinase receptor activation of phospholipase D1 (PLD1) play key roles in agonist-stimulated cellular responses such as regulated exocytosis, actin stress fiber formation, and alterations in cell morphology and motility. Protein Kinase C, ADP-ribosylation factor (ARF), and Rho family members activate PLD1 in vitro; however, the actions of the stimulators on PLD1 in vivo have been proposed to take place through indirect pathways. We have used the yeast split-hybrid system to generate PLD1 alleles that fail to bind to or to be activated by RhoA but that retain wild-type responses to ARF and PKC. These alleles then were employed in combination with alleles unresponsive to PKC or to both stimulators to examine the activation of PLD1 by G protein-coupled receptors. Our results demonstrate that direct stimulation of PLD1 in vivo by RhoA (and by PKC) is critical for significant PLD1 activation but that PLD1 subcellular localization and regulated phosphorylation occur independently of these stimulatory pathways.


Subject(s)
Heterotrimeric GTP-Binding Proteins/metabolism , Phospholipase D/metabolism , Protein Kinase C/physiology , Signal Transduction , rhoA GTP-Binding Protein/physiology , ADP-Ribosylation Factor 1/physiology , Alleles , Animals , COS Cells , Cell Line , Intracellular Membranes/enzymology , Mutation , Phospholipase D/genetics , Phosphorylation , Receptors, Cell Surface/metabolism , Two-Hybrid System Techniques
8.
Mar Pollut Bull ; 124(2): 811-818, 2017 Nov 30.
Article in English | MEDLINE | ID: mdl-27919420

ABSTRACT

The toxicity of the antifouling biocides Irgarol 1051, Diuron, Chlorothalonil, Dichlofluanid, Sea-nine 211, Copper pyrithione, Zinc pyrithione, Ziram and Zineb were evaluated on Nitzschia pungens and Artemia larvae. Results showed that EC50 for Irgarol 1051 was 0.586Āµgl-1 was the strongest effect on N. pungens following by Copper pyrithione (4.908Āµgl-1), Ziram (5.421Āµgl-1), Zinc pyrithione (5.513Āµgl-1), Diuron (6.640Āµgl-1), Zineb (232.249Āµgl-1), Sea-nine 211(267.368Āµgl-1), Chlorothalonil (360.963Āµgl-1) and Dichlofluanid (377.010Āµgl-1) in 96h. In Artemia larvae, the biocides were evaluated the LC50 for larval survivals at 48h. Sea-nine 211 and Copper pyrithione were 0.318 and 0.319mgl-1. Chlorothalonil, Zinc pyrithione and Ziram were 2.683, 3.147 and 4.778mgl-1. Irgarol 1051, Diuron, Zineb and Dichlofluanid were 9.734, 30.573, 41.170 and 154.944mgl-1. These results provide baseline data concerning the toxicity of antifouling biocides against marine environment.


Subject(s)
Artemia/drug effects , Diatoms/drug effects , Disinfectants/toxicity , Phytoplankton/drug effects , Zooplankton/drug effects , Aniline Compounds/toxicity , Animals , Dimethyl Sulfoxide , Diuron/toxicity , Larva/drug effects , Nitriles/toxicity , Organometallic Compounds/toxicity , Pyridines/toxicity , Toxicity Tests, Acute , Triazines/toxicity , Water Pollutants, Chemical/toxicity
10.
Cancer Res ; 54(8): 2240-4, 1994 Apr 15.
Article in English | MEDLINE | ID: mdl-8174133

ABSTRACT

Phosphoinositide-specific phospholipase C (PLC) isozymes occupy a central role in the signal transduction system by regulating various cellular processes including proliferation and differentiation. In the present study, we examined the contents of PLCs in colorectal adenomas, carcinomas, and normal mucosa obtained from 4 familial adenomatous polyposis patients to find out whether this enzyme plays any role in the pathogenesis of adenomas and/or carcinomas in familial adenomatous polyposis. Radioimmunoassay and immunoblot analysis revealed that in contrast to little difference in PLC-beta 1 and PLC-delta 1 content, a considerably higher level of PLC-gamma 1 was detected in 3 of 4 cases for adenoma and in all cases for carcinoma as compared to normal mucosa. The level of PLC-gamma 1 expression increased from normal mucosa to adenoma, and finally to carcinoma progressively. Immunohistochemical findings also confirmed this observation. Likewise, activity of PLC-gamma 1 was considerably higher in adenomas and carcinomas than in normal mucosa. These results suggest that PLC-gamma 1-mediated signal transduction may play a significant role in the progression of colorectal tumors in patients with familial adenomatous polyposis.


Subject(s)
Adenomatous Polyposis Coli/enzymology , Intestinal Mucosa/enzymology , Isoenzymes/biosynthesis , Type C Phospholipases/biosynthesis , Adenoma/enzymology , Adenoma/pathology , Adenoma/surgery , Adenomatous Polyposis Coli/pathology , Adenomatous Polyposis Coli/surgery , Adult , Carcinoma/enzymology , Carcinoma/pathology , Carcinoma/surgery , Colorectal Neoplasms/enzymology , Colorectal Neoplasms/pathology , Colorectal Neoplasms/surgery , Female , Gene Expression , Humans , Immunohistochemistry , Intestinal Mucosa/pathology , Isoenzymes/analysis , Male , Middle Aged , Radioimmunoassay , Type C Phospholipases/analysis
11.
Cancer Res ; 57(24): 5465-8, 1997 Dec 15.
Article in English | MEDLINE | ID: mdl-9407951

ABSTRACT

Phospholipase C-gamma1 (PLC-gamma1) mediates signals from various extracellular origins to evoke cellular events such as mitogenesis. Previously, we reported that PLC-gamma1 was highly expressed in colorectal cancer and familial adenomatous polyposis, suggesting that PLC-gamma1 might be oncogenic. In this study, we have established rat 3Y1 fibroblasts that overexpress whole PLC-gamma1 and src homology 2 (SH2)-SH2-SH3 domain of PLC-gamma1. These cells showed a transformed phenotype and were tumorigenic when transplanted into nude mice. These results indicate that overexpression of PLC-gamma1 could transform rat fibroblasts, and the transformation is mediated by SH2-SH2-SH3 domain of PLC-gamma1.


Subject(s)
Cell Transformation, Neoplastic , Fibroblasts/cytology , Fibroblasts/enzymology , Isoenzymes/physiology , Type C Phospholipases/physiology , Animals , Cells, Cultured , Isoenzymes/biosynthesis , Mice , Mice, Nude , Phospholipase C gamma , Rats , Transfection , Type C Phospholipases/biosynthesis , src Homology Domains
12.
Oncogene ; 20(55): 7954-64, 2001 Nov 29.
Article in English | MEDLINE | ID: mdl-11753678

ABSTRACT

Phospholipase C-gamma1(PLC-gamma1) is known to play an essential role in various cellular responses, such as proliferation and tumorigenesis, and PLC-gamma1-specific inhibitors are commonly employed to investigate the mechanism of the PLC-gamma1-mediated signaling pathway. In this study, we developed a single chain antibody fragment (scFv) as a blocker for PLC-gamma1 mediated signaling. scFv, designated F7-scFv, specifically bound to PLC-gamma1 with high affinity (K(d)=1.9x10(-8) M) in vitro. F7-scFv also bound to PLC-gamma1 in vivo and altered the distribution pattern of PLC-gamma1 from the cytoplasm to the intracellular aggregates, where F7-scFv was localized. Moreover, F7-scFv interrupted the EGF-induced translocation of PLC-gamma1 from the cytosol to the membrane ruffle and attenuated EGF-induced inositol phosphates generation and intracellular calcium mobilization. These results indicate that F7-scFv blocks EGF-induced PLC-gamma1 activation by causing sequestering of PLC-gamma1 into intracellular aggregates, and may therefore be useful in studies of the PLC-gamma1-mediated signaling pathway.


Subject(s)
Epidermal Growth Factor/pharmacology , Immunoglobulin Fragments/immunology , Immunoglobulin Fragments/pharmacology , Isoenzymes/antagonists & inhibitors , Isoenzymes/immunology , Type C Phospholipases/antagonists & inhibitors , Type C Phospholipases/immunology , Amino Acid Sequence , Animals , Antibodies, Monoclonal/chemistry , Antibodies, Monoclonal/immunology , Antibodies, Monoclonal/pharmacology , Antibody Affinity , Base Sequence , COS Cells , Calcium Signaling/drug effects , Cell Line , Enzyme Activation/drug effects , Enzyme-Linked Immunosorbent Assay , Fluorescein-5-isothiocyanate , Hybridomas/cytology , Hybridomas/immunology , Immunoglobulin Fragments/chemistry , Inositol Phosphates/metabolism , Isoenzymes/metabolism , Kinetics , Mice , Microscopy, Fluorescence , Molecular Sequence Data , Phospholipase C gamma , Protein Transport/drug effects , Thermodynamics , Type C Phospholipases/metabolism
13.
Biochim Biophys Acta ; 1485(2-3): 153-62, 2000 May 31.
Article in English | MEDLINE | ID: mdl-10832096

ABSTRACT

Primary cultures of rat cortical astrocytes express phospholipase D (PLD) isoforms 1 and 2 as determined by RT-PCR and Western blot. Basal PLD activity was strongly (10-fold) increased by 4beta-phorbol-12beta,13alpha-dibutyrate (PDB) (EC(50): 56 nM), an effect which was inhibited by Ro 31-8220 (0.1-1 microM), an inhibitor of protein kinase C (PKC), and by brefeldin A (10-100 microg/ml), an inhibitor of ADP-ribosylating factor (ARF) activation. Pretreatment of the cultures with Clostridium difficile toxin B-10463 (0.1-1 ng/ml), which inactivates small G proteins of the Rho family, led to a breakdown of the astroglial cytoskeleton; concomitantly, PLD activation by PDB was reduced by up to 50%. In contrast, inactivation of proteins of the Ras family by Clostridium sordellii lethal toxin 1522 did not affect PLD activation. In parallel experiments, serum-induced PLD activation was sensitive to brefeldin A, but not to Ro 31-8220 and not to clostridial toxins. We conclude that, in astrocytes, the PLD isoform which is activated by phorbol ester requires PKC, ARF and Rho proteins for full activity and probably represents PLD1.


Subject(s)
ADP-Ribosylation Factors/metabolism , Astrocytes/enzymology , Bacterial Proteins , Phospholipase D/metabolism , rho GTP-Binding Proteins/metabolism , Animals , Astrocytes/cytology , Astrocytes/drug effects , Bacterial Toxins/pharmacology , Brefeldin A/pharmacology , Cells, Cultured , Enzyme Activation , Enzyme Inhibitors/pharmacology , Indoles/pharmacology , Phorbol Esters/pharmacology , Phospholipase D/genetics , Protein Kinase C/antagonists & inhibitors , Protein Synthesis Inhibitors/pharmacology , Rats , Rats, Sprague-Dawley , Serum Albumin, Bovine/pharmacology
14.
Biochim Biophys Acta ; 1346(2): 103-8, 1997 Jun 02.
Article in English | MEDLINE | ID: mdl-9219893

ABSTRACT

Monoclonal antibodies were generated against the purified pancreatic cholesterol ester hydrolase (CEH, EC 3.1.1.13) to examine the expression of CEH in various bovine tissues. The presence of CEH isozyme antigenically indistinguishable from pancreatic enzyme in the steroidogenic tissues, adrenal glands and testis has been first demonstrated here using the immunoprecipitation method. These results suggest that CEH isozyme, similar to pancreatic CEH, might be involved in the cholesterol metabolism in the steroidogenic tissue.


Subject(s)
Adrenal Glands/enzymology , Sterol Esterase/analysis , Testis/enzymology , Animals , Antibodies, Monoclonal , Blotting, Western , Cattle , Chromatography, High Pressure Liquid , Isoenzymes/analysis , Isoenzymes/immunology , Male , Pancreas/immunology , Precipitin Tests , Sterol Esterase/immunology , Sterol Esterase/isolation & purification
15.
Biochim Biophys Acta ; 1389(1): 76-80, 1998 Jan 05.
Article in English | MEDLINE | ID: mdl-9443606

ABSTRACT

Phospholipase C-beta1 (PLC-beta1), one of the PLC-beta isozymes, exists as two immunologically distinguishable polypeptides of 150 (PLC-beta1a) and 140 kDa (PLC-beta1b) which are encoded in two distinct transcripts and generated by alternative splicing of a single gene. In this study, the subcellular localization of the two phospholipases C-beta1 proteins was examined in rat C6Bu-1 glioma cells using immunological techniques. Immunoblot analysis revealed that the two forms of PLC-beta1 were detectable in both cytosolic and nuclear fractions. PLC-beta1a appeared to be located preferentially in the cytosol, whereas PLC-beta1b was found predominantly in the nuclei of C6Bu-1 cells. Immunocytochemical experiments confirmed the differential localization of the two PLC-beta1 species in C6Bu-1 cells. These results suggest that the two PLC-beta1 proteins may have different physiological roles in the cell.


Subject(s)
Cell Nucleus/enzymology , Cytosol/enzymology , Isoenzymes/analysis , Type C Phospholipases/analysis , Alternative Splicing , Animals , Antibodies/immunology , Blotting, Western , Cell Fractionation , Glioma , Immunoblotting , Immunohistochemistry , Isoenzymes/chemistry , Isoenzymes/immunology , Phospholipase C beta , Rats , Tumor Cells, Cultured , Type C Phospholipases/chemistry , Type C Phospholipases/immunology
16.
Biochim Biophys Acta ; 1440(2-3): 235-43, 1999 Sep 22.
Article in English | MEDLINE | ID: mdl-10521707

ABSTRACT

Ultraviolet-C (UVC) irradiation induces DNA damage and UVC-irradiated cells undergo cell growth arrest to repair the damaged DNA or the induction of apoptosis to prevent the risk of neoplastic transformation. Phospholipase C-gamma1 (PLC-gamma1) is a mediator of growth factor induced-signal cascade, catalyzing the hydrolysis of phosphatidyl 4,5-bisphosphate to generate second messengers, diacylglycerol and inositol 1,4,5-trisphosphate (IP(3)). PLC-gamma1 is activated by phosphorylation of tyrosine residues upon occupation of cell surface receptors by growth factors and plays an important role in controlling cellular proliferation and differentiation. In this study, we found that PLC-gamma1 was tyrosine phosphorylated within 2.5 min after UVC irradiation. To investigate the role of UVC-induced tyrosine phosphorylation of PLC-gamma1, we compared the effect of UVC between PLC-gamma1 overexpressing cells and empty vector transfected cells. Overexpression of PLC-gamma1 inhibited UVC-induced sub-diploid peak and DNA fragmentation. Northern blot analysis revealed that UVC-induced c-fos mRNA accumulation was inhibited in PLC-gamma1 overexpressing cells, while c-jun expression was not affected. In addition, UVC-induced activation of c-Jun N-terminal kinase (JNK) was significantly suppressed in PLC-gamma1 overexpressing cells. These results suggest that PLC-gamma1 may associate with the protective function against the UVC-induced cell death progression via the inhibition of accumulation of c-fos mRNA and the inhibition of JNK kinase activity.


Subject(s)
Apoptosis , Isoenzymes/biosynthesis , Mitogen-Activated Protein Kinases/antagonists & inhibitors , PC12 Cells/radiation effects , Type C Phospholipases/biosynthesis , Animals , Down-Regulation , Enzyme Activation , Genes, fos , Genes, jun , JNK Mitogen-Activated Protein Kinases , Mitogen-Activated Protein Kinases/analysis , PC12 Cells/enzymology , Phospholipase C gamma , Rats , Transcription, Genetic/radiation effects , Transfection , Ultraviolet Rays
17.
Biochim Biophys Acta ; 1436(3): 319-30, 1999 Jan 04.
Article in English | MEDLINE | ID: mdl-9989263

ABSTRACT

The subcellular location of phospholipase D1 (PLD1) and its activation by protein kinase C alpha (PKC alpha) were examined by subcellular fractionation and by microscopic observation of green fluorescent protein-fused PLD1 (GFP-PLD1) or PKC alpha (GFP-PKC alpha) in fibroblastic 3Y1 cells. Major PLD1 immunoreactivity and PKC alpha-stimulated PLD activity segregated with a plasma membrane marker, even though a significant amount was co-fractionated with markers for endoplasmic reticulum (ER) and Golgi. Upon treatment with phorbol myristate acetate (PMA), PKC alpha translocated from the cytosolic fraction to the membrane fraction to which PLD1 also localized. GFP-PLD1 was found in the plasma membrane as well as a in a perinuclear compartment consistent with ER and Golgi and in other dispersed vesicular structures in the cytoplasm. However, most of GFP-PKC alpha was translocated from the cytosol to the plasma membrane after treatment with PMA. From these results, we concluded that the plasma membrane is the major site of PLD1 activation by PKC alpha in 3Y1 cells.


Subject(s)
Cell Membrane/enzymology , Isoenzymes/metabolism , Phospholipase D/metabolism , Protein Kinase C/metabolism , Animals , Biological Transport, Active/drug effects , Cell Line , Endoplasmic Reticulum/enzymology , Enzyme Activation/drug effects , Gene Expression , Golgi Apparatus/enzymology , Green Fluorescent Proteins , Isoenzymes/genetics , Luminescent Proteins/genetics , Luminescent Proteins/metabolism , Microscopy, Fluorescence , Phospholipase D/genetics , Protein Kinase C/genetics , Protein Kinase C-alpha , Rats , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Subcellular Fractions/enzymology , Tetradecanoylphorbol Acetate/pharmacology
18.
Biochim Biophys Acta ; 1347(2-3): 199-204, 1997 Aug 16.
Article in English | MEDLINE | ID: mdl-9295164

ABSTRACT

A phospholipase D1 (PLD1) was purified from rat brain by the use of antibody-coupled protein A Sepharose. We found that protein kinase C alp (PKCalpha) stimulated PLD1 activity in the presence of phorbol myristate acetate (PMA). PMA-dependent association of PKCalpha with PLD1 was verified in NIH-3T3 fibroblast cells, and COS7 cells transiently expressing PLD1 as well as in vitro suggesting that the activation of PLD1 resulted from direct association of PKCalpha with PLD1.


Subject(s)
Phospholipase D/metabolism , Protein Kinase C/metabolism , Tetradecanoylphorbol Acetate/pharmacology , 3T3 Cells , Animals , Brain/enzymology , COS Cells , Enzyme Activation , Mice , Phospholipase D/isolation & purification , Phosphorylation
19.
J Leukoc Biol ; 66(6): 915-22, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10614772

ABSTRACT

Trp-Lys-Tyr-Met-Val-D-Met (WKYMVm) is a synthetic peptide that stimulates phosphoinositide (PI) hydrolysis in human leukocytes. The peptide binds to a unique cell surface receptor(s). Recently we had demonstrated that human neutrophils, monocytes, and B lymphocytes express this peptide-specific receptor and that stimulation of human leukocytes with the peptide leads to activation of the oxidative respiratory system and the bactericidal activity of neutrophils or monocytes. In this study we showed that the peptide induces chemotaxis of phagocytic leukocytes and studied the signaling pathway leading to chemotaxis in human monocytes. The peptide-induced monocyte chemotaxis is pertussis toxin (PTX)-sensitive. This fact correlates with the peptide's stimulation of PI hydrolysis and intracellular Ca2+ ([Ca2+]i) release, which is also PTX-sensitive. We demonstrate that the peptide-specific receptor is different from receptor(s) for monocyte chemoattractant protein-1 (MCP-1). We also show that intracellular signaling of WKYMVm leading to monocyte chemotaxis is different from that of MCP-1. The peptide-mediated monocyte chemotaxis is insensitive to protein kinase C (PKC) inhibitor (GF109203X) and butan-1-ol, ruling out PKC and phospholipase D participation in this process. On the other hand, a tyrosine kinase inhibitor (genistein) and RhoA inhibitor (C3 transferase) curtailed the peptide-induced chemotaxis in a concentration-dependent manner, implying the involvement of tyrosine kinase and RhoA, respectively. Treatment of human monocytes with the peptide stimulates tyrosine phosphorylation of several cellular proteins, including p125FAK and Pyk2 and translocation of RhoA from the cytosol to the membrane. We conclude that WKYMVm induces chemotaxis of human phagocytic leukocytes via unique receptors and signaling.


Subject(s)
Chemotaxis, Leukocyte/drug effects , Monocyte Chemoattractant Proteins/pharmacology , Monocytes/drug effects , Neutrophils/drug effects , Oligopeptides/pharmacology , 1-Butanol/pharmacology , B-Lymphocytes/cytology , B-Lymphocytes/drug effects , B-Lymphocytes/physiology , Chemokine CCL2/physiology , Chemotaxis, Leukocyte/physiology , Enzyme Inhibitors/pharmacology , GTP-Binding Proteins/metabolism , GTP-Binding Proteins/physiology , Humans , Indoles/pharmacology , Maleimides/pharmacology , Monocytes/cytology , Monocytes/enzymology , Monocytes/physiology , Neutrophils/cytology , Neutrophils/physiology , Pertussis Toxin , Phospholipase D/antagonists & inhibitors , Phospholipase D/metabolism , Protein-Tyrosine Kinases/antagonists & inhibitors , Protein-Tyrosine Kinases/metabolism , Receptors, CCR2 , Receptors, Chemokine/physiology , Virulence Factors, Bordetella/pharmacology , rhoA GTP-Binding Protein/physiology
20.
J Leukoc Biol ; 67(5): 630-6, 2000 May.
Article in English | MEDLINE | ID: mdl-10811002

ABSTRACT

Extracellular hydrogen peroxide (H2O2) has been implicated in the activation of phospholipase D (PLD). However, it was still unclear how this activation occurs and what the molecular identity of the H2O2-stimulated PLD isozyme is. This study shows that H2O2 potently increases the PLD activity in mouse lymphocytic leukemic L1210 cells, which contain exclusively PLD2. In addition, H2O2 increased PLD activity only in PLD2-transfected COS-7 cells and not in PLD1-transfected cells. This suggests that PLD2 is selectively activated by H2O2. Depletion of extracellular Ca2+ with EGTA completely blocked the H2O2-induced PLD activation, indicating that Ca2+ influx is required. Moreover, pretreatment of the cells with the protein kinase C (PKC) inhibitors GF-109203X and RO-31-8220 and down-regulation of PKCalpha by prolonged treatment with 4beta-phorbol 12-myristate 13-acetate inhibited the H2O2-stimulated PLD2 activity, which points to the involvement of PKCalpha. Based on these new findings we suggest that PLD2 activity is specifically up-regulated by H2O2 and that the H2O2-induced PLD2 activation is mediated by Ca2+ influx and PKCalpha activation.


Subject(s)
Hydrogen Peroxide/pharmacology , Leukemia L1210/enzymology , Phospholipase D/metabolism , Animals , COS Cells , Calcium/physiology , Edetic Acid/pharmacology , Enzyme Activation , Enzyme Inhibitors/pharmacology , Humans , Indoles/pharmacology , Isoenzymes/metabolism , K562 Cells , Kinetics , Maleimides/pharmacology , Mice , Phospholipase D/genetics , Protein Kinase C/antagonists & inhibitors , Protein Kinase C/metabolism , Protein Kinase C-alpha , Recombinant Proteins/metabolism , Transfection , U937 Cells
SELECTION OF CITATIONS
SEARCH DETAIL